82 completed, 9 unknown, 6 terminated, 5 recruiting. 40 Phase 3, 36 Phase 4, 17 Phase 2, 8 Not applicable, 4 Phase 1.
Follow this drug Literature Review of Hepatitis A Vaccines trials Research Report on Hepatitis A Vaccines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ⅲ Clinical Trial of an Inactivated Hepatitis A Vaccine Inactivated Hepatitis A Vaccine (Human Diploid Cell) (1 mL), Inactivated Hepatitis A Vaccine (Human Diploid Cell) (0.5 mL), Hepatitis A vaccine (inactivated, adsorbed) - Hepatitis A Vaccine | Phase 3 | Recruiting | Sinovac Biotech Co., Ltd | 680 | 2026-08-20 | 2026-08-28 |
| From Conflict to Family Trauma The aim of this research is to record how many families go to court for the breakdown of parent-child relationships and to understand how many of these families, one year after the judge's ruling, hav - Family Conflict, Family Characteristics | Not yet recruiting | University of Bari Aldo Moro | 200 | 2026-02-08 | 2025-08-21 | |
| Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines trivalent inactivated influenza vaccine (TIV), nonavalent HPV vaccine (HPV), hepatitis A (HAV) vaccines - Immunology, Healthy Adults | Phase 4 | Active not recruiting | Washington University School of Medicine | 25 | 2025-08-26 | 2026-07-01 |
| A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age Investigational varicella vaccine, Marketed varicella vaccine, MMR vaccine - Chickenpox | Phase 3 | Recruiting | GlaxoSmithKline | 600 | 2025-05-15 | 2026-05-29 |
| A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age Candidate varicella vaccine, Marketed varicella vaccine, MMR vaccine - Chickenpox | Phase 3 | Recruiting | GlaxoSmithKline | 911 | 2025-04-17 | 2026-05-29 |
| Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age PCV21 vaccine, Prevnar 20 vaccine, M-M-R II vaccine - Pneumococcal Immunization | Phase 3 | Active not recruiting | Sanofi | 580 | 2025-02-27 | 2026-02-13 |
| Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age PCV21 vaccine, Prevnar 20 vaccine, M-M-R II vaccine - Pneumococcal Immunization | Phase 3 | Active not recruiting | Sanofi | 2360 | 2025-02-18 | 2026-04-13 |
| A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age Investigational varicella vaccine_Lot 1, Investigational varicella vaccine_Lot 2, Investigational varicella vaccine_Lot 3 - Chickenpox | Phase 3 | Recruiting | GlaxoSmithKline | 1840 | 2025-01-10 | 2026-05-29 |
| A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age Investigational varicella vaccine, Marketed varicella vaccine, Measles, mumps, and rubella vaccine - Chickenpox | Phase 3 | Recruiting | GlaxoSmithKline | 750 | 2024-11-26 | 2026-05-29 |
| Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis HAVRIX - Cirrhosis, Hep A | Phase 4 | Unknown | Mahidol University | 50 | 2024-02-29 | 2024-03-19 |
| Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination. Hepatitis A Vaccine - Hepatitis A | Phase 4 | Unknown | Best Healthcare Inc. | 300 | 2024-01-01 | 2023-12-28 |
| Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People 2 doses of HAV, At least one dose of HAV - Hepatitis A, Immunodeficiency | Phase 4 | Completed | LiuZhou People's Hospital | 392 | 2023-12-19 | 2025-12-31 |
| Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children mRNA COVID-19 Vaccine, Routine Childhood Vaccinations - Fever After Vaccination, Fever | Phase 4 | Completed | Duke University | 347 | 2023-10-30 | 2026-05-13 |
| Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV) - Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1528 | 2023-03-27 | 2026-01-21 |
| The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd) Hepatitis A vaccine, Diphtheria, pertussis, and tetanus booster vaccine - Rheumatic Diseases | Phase 4 | Terminated | Oregon Health and Science University | 129 | 2022-10-11 | 2026-09-24 |
| A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age Investigational varicella vaccine low potency, Investigational varicella vaccine medium potency, Investigational varicella vaccine high potency - Chickenpox | Phase 2 | Completed | GlaxoSmithKline | 800 | 2022-02-03 | 2025-02-28 |
| Use of Virtual Reality in the Reduction of Pain After the Administration of Vaccines Among Children in Primary Care Centers. Pico G2 Virtual Reality Glasses (Pico Interactive Inc), together with an Android AOYODKG tablet, Traditional Distractors, Triple Viral + Varicella Vaccine at 3 years of age - Pain, Pediatrics | Not applicable | Completed | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 300 | 2022-01-18 | 2024-03-15 |
| Safety and Immunogenicity of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adults With Chronic Immune-Mediated Diseases CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Havrix, Placebo; 0.9% saline - COVID-19 | Phase 3 | Terminated | Clover Biopharmaceuticals AUS Pty | 1 | 2021-11-12 | 2023-03-24 |
| R21/Matrix-M in African Children Against Clinical Malaria R21/Matrix-M, Rabies vaccine, Hepatitis A vaccine or Meningococcal vaccine - Malaria | Phase 3 | Active not recruiting | University of Oxford | 4800 | 2021-04-29 | 2026-02-23 |
| Evaluation of the Safety and Immunogenicity of Hepatitis A Vaccine Hepatitis A (Live) Vaccine, Freeze-dried produced by Changchun, Hepatitis A (Live) Vaccine, Freeze-dried produced by Zhejiang, Hepatitis A (Live) Vaccine, Freeze-dried produced by the Institute of Medical Biology, CAMS - Vaccination | Phase 4 | Unknown | China National Biotec Group Company Limited | 450 | 2020-11-12 | 2021-02-26 |
Showing 20 of 111. Sign in to see all of them.
Hepatitis A (28) · Hepatitis (13) · Chickenpox (10) · HIV Infections (9) · Measles (8) · Mumps (7) · Rubella (7) · Haemophilus Infections (5) · Hepatitis B (5) · Streptococcal Infections (5) · Arthritis, Rheumatoid (4) · Influenza, Human (4) · Meningococcal Infections (4) · Pneumococcal Infections (4) · Typhoid Fever (4)
GlaxoSmithKline (36) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Sanofi Pasteur, a Sanofi Company (7) · Merck Sharp & Dohme LLC (4) · International Vaccine Institute (3) · Sinovac Biotech Co., Ltd (3) · Canadian Immunization Research Network (2) · Centers for Disease Control and Prevention (2) · China National Biotec Group Company Limited (2) · Sanofi (2) · Arto Palmu (1) · Best Healthcare Inc. (1) · Chuncheon Sacred Heart Hospital (1) · Clover Biopharmaceuticals AUS Pty (1) · CureVac (1)
United States (41) · Belgium (11) · Puerto Rico (11) · Finland (10) · Canada (9) · Thailand (9) · China (8) · Estonia (7) · Poland (7) · Czechia (5) · Germany (5) · Mexico (5) · Panama (5) · Spain (5) · Colombia (4)
Adrian VS Hill, PhD (1) · Anu Kantele, Assoc. prof. (1) · Arto A Palmu, M.D. (1) · Astrid Kaltenboeck, Ph.D. (1) · Beth P Bell, MD, MPH (1) · Brian McMahon (1) · Canh G Do, MD (1) · Chien-Ching Hung, MD (1) · Christoph Hatz, Professor (1) · Christos M Tsoukas, MD, FRCPC (1)
PMID 32710245, PMID 21366801, PMID 24508042, PMID 26190091, PMID 34986178, PMID 11855555, PMID 16708058, PMID 17109339, PMID 17259872, PMID 17947390, PMID 18752430, PMID 19617848, PMID 19625715, PMID 20215608, PMID 20856164, PMID 22094635, PMID 22098676, PMID 22216840, PMID 22265115, PMID 22537990, PMID 22777096, PMID 22894958, PMID 23121249, PMID 23158882, PMID 23744509, PMID 23839107, PMID 24285844, PMID 24287186, PMID 24328444, PMID 24465570, PMID 24656175, PMID 24820104, PMID 25127244, PMID 26083474, PMID 26284652, PMID 26302024, PMID 26551446, PMID 26770041, PMID 27125273, PMID 27427877, PMID 27686833, PMID 27815383, PMID 27846060, PMID 27977707, PMID 28481690, PMID 28507927, PMID 28887164, PMID 29140444, PMID 29236639, PMID 29503110
2008 (2), 2018 (2), 2014 (1), P01CA015396 (1), P30CA012197 (1), R01AI130398 (1), U01AI141990 (1), U19AI181103 (1)